Chiron Appoints Jack Goldstein President and Chief Operating Officer
Chiron Corporation announced the appointment of Jack Goldstein, 57, to the position of president and chief operating officer. Dr. Goldstein has served in this capacity on an interim basis since November 2004 and previously served as president of Chiron Blood Testing.
As president and COO, Dr. Goldstein will continue to oversee Chiron's day-to-day business operations and report to CEO Howard Pien. Mr. Pien will continue to set the direction of the organization, leading the executive committee in establishing strategy and realizing objectives, as well as guide Chiron's remediation efforts for the company's Liverpool manufacturing facility, which produces FLUVIRIN(R) influenza virus vaccine.
Chiron also announced the appointments of Gene Walther, 50, as president of Chiron Blood Testing, following his appointment as acting president of Chiron Blood Testing in November, and Daniel Soland, 46, as president of Chiron Vaccines. Mr. Walther was previously vice president for Chiron Blood Testing commercial operations, Americas. Mr. Soland, who brings more than two decades of pharmaceuticals and vaccines experience, succeeds John Lambert, who has resigned his position with Chiron. Both Mr. Walther and Mr. Soland will report to Dr. Goldstein.
Other news from the department people
